Guidelines for aerosol devices in infants, children and adults: Which to choose, why and how to achieve effective aerosol therapy

Expert Review of Respiratory Medicine

Volumn 5, Issue 4, 2011, Pages 561-572

  Ari, Arzu ^a   Fink, James B ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

aerosol device; aerosols; drug; dry powder inhaler; environment and pulmonary diseases; metered dose inhaler; nebulizers; patients

Indexed keywords

CORTICOSTEROID; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; SALBUTAMOL;

AEROSOL; CATARACT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; DEVICE; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DYSPHONIA; ENVIRONMENTAL FACTOR; EYE DISEASE; FACE MASK; GLAUCOMA; HEALTH CARE COST; HOARSENESS; HUMAN; LUNG DISEASE; MEDICAL NEBULIZER; METERED DOSE INHALER; PATIENT ATTITUDE; PRACTICE GUIDELINE; REIMBURSEMENT; REVIEW; SKIN DISEASE; THRUSH;

EID: 80052631654     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.11.49     Document Type: Review

References (107)

1. Dolovich MB, Ahrens RC, Hess DR et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 127, 335-371 (2005). (Pubitemid 41724594)
2. Molimard M, Rahersion C, Lignot S. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J. Aerosol Med. 16, 249-254 (2003). (Pubitemid 37169635)
3. Watts AB, McConville JT, Williams RO 3rd. Current therapies and technological advances in aqueous aerosol drug delivery. Drug Dev. Ind. Pharm. 34, 913-922 (2008).
4. Dalby R, Spallek M, Voshaar T. A review of the development of Respimat soft mist inhaler. Int. J. Pharm. 283, 1-9 (2004). (Pubitemid 39200921)
5. Fink J, Hodder R. Adherence and inhaler devices in COPD. Respir. Ther. 6, 28-33 (2011).
6. Fink JB. Aerosol drug therapy. In: Egan's Fundamentals of Respiratory Care. Mosby Elsevier, MO, USA, 801-842 (2009).
7. Hess DR. Aerosol delivery devices in the treatment of asthma. Respir. Care 53, 699-723 (2008).
8. Fink JB, Rubin BK. Aerosol and medication administration. In : Perinatal and Pediatric Respiratory Care. Czerviske MP, Barnhart SL (Eds). Elsevier Science MO, USA (2003).
9. Rau JL. Practical problems with aerosol therapy in COPD. Respir. Care 51(2), 158-172 (2006). (Pubitemid 46888414)
10. Rubin BK. Nebulizer therapy for children: the device-patient interface. Respir. Care 47(11), 1314-1319 (2002).
11. Boe J, Dennis JH, O'Driscoll BR et al. European respiratory society guidelines on the use of nebulizers. Eur. Respir. J. 18(1), 228-242 (2001). (Pubitemid 32717452)
12. Everard ML. Aerosol delivery to children. Pediatr. Ann. 35(9), 630-636 (2006). (Pubitemid 44448980)
13. Everard ML. Inhalation therapy for infants.Adv. Drug Deliv. Rev. 55(7), 869-878 (2003). (Pubitemid 36776798)
14. Ahrens RC. The role of the MDI and DPI in pediatric patients: 'children are not just miniature adults'. Respir. Care 50(10), 1323-1328 (2005). (Pubitemid 46173317)
15. Pongracic JA. Asthma delivery devices: age-appropriate use. Pediatr. Ann. 32(1), 50-54 (2003). (Pubitemid 36077940)
16. Rubin BK, Fink JB. Optimizing aerosol delivery by pressurized metered-dose inhalers. Respir. Care 50(9), 1191-1200 (2005).
17. Rubin B, Fink J. The delivery of inhaled medication to the young children. Pediatr. Clin. North Am. 50(3), 717-731 (2003). (Pubitemid 36807614)
18. Everard ML. Inhaler devices in infants and children: challenges and solutions. J. Aerosol Med. 17, 186-195 (2004). (Pubitemid 38955680)
19. Everard ML. Guidelines for devices and choices. J. Aerosol Med. 14(Suppl. 1), S59-S64 (2001). (Pubitemid 32172854)
20. Ritson SD, Everard ML. Aerosol delivery systems acceptable to young children improve drug delivery. Thorax 53(Suppl. 4), A55 (1998). (Pubitemid 128777480)
21. Fink J. Aerosol delivery to ventilated infants and pediatric patients. Respir. Care 49(6), 653-665 (2004).
22. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir. Care 50(10), 1360-1374 (2005). (Pubitemid 46173323)
23. Lewis RM, Fink JB. Promoting adherence to inhaled therapy: building partnerships through patient education. Respir. Care Clin. N. Am. 7(2), 277-301 (2001).
24. Fink JB. Inhalers in asthma management: is demonstration the key to compliance? Respir. Care 50(5), 598-600 (2005). (Pubitemid 46190326)
25. Cipolla D, Chan H, Schuster J, Farina D. Personalizing aerosol medicine: development of delivery systems tailored to the individual. Therapeutic Delivery 1, 667-682 (2010).
26. Geller DE. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respir. Care 50(10), 1313-1321 (2005). (Pubitemid 46173315)
27. Rau JL. The inhalation of drugs: advantages and problems. Respir. Care 50(3), 367-382 (2005). (Pubitemid 46179556)
28. Castro-Rodriguez JA, Rodrigo GJ. b-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J. Pediatr. 145(2), 172-177 (2004). (Pubitemid 38993387)
29. Meadows-Oliver M, Banasiak NC. Asthma medication delivery devices. J. Pediatr. Health Care 19(2), 121-123 (2005). (Pubitemid 40327172)
30. Nikander K, Agertoft L, Pedersen S. Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide. J. Asthma 37(5), 451-459 (2000).
31. Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constantoutput, breath-enhanced, and dosimetric. Respiratory Care 49(2), 174-179 (2004).
32. Silver W, Cohen R, D'Alonzo G et al. Comparative taste evaluation of aerosolized formulations of triamcinolone acetonide flunisolide and flunisolide with menthol. Clin. Ther. 15(8), 988-993 (1993). (Pubitemid 24045900)
33. Osman L, Hyland M. Patient needs and medication styles in COPD. Eur. Respir. Rev. 14(96), 89-92 (2005). (Pubitemid 43028764)
34. Crompton G. The adult patient's difficulties with inhalers. Lung 168, S658-S662 (1990).
35. Nikander K. Adaptive aerosol delivery: the principles. Eur. Respir. Rev. 7, 385-387 (1997). (Pubitemid 28089980)
36. Denyer J. Adaptive aerosol delivery in practise. Eur. Respir. Rev. 7, 388-389 (1997).
37. Nikander K, Arheden L, Denyer J, Cobos N. Parents' adherence with nebulizer treatment of their children when using an adaptive aerosol delivery (AAD) system. J. Aerosol Med. 16(3), 273-281 (2003). (Pubitemid 37169638)
38. Hussain-Rizvi A, Kunkov S, Crain EF. Does parental involvement in pediatric emergency department asthma treatment affect home management? J. Asthma 46(8), 792-795 (2009).
39. Everard ML. Aerosol therapy: regimen and device compliance in daily practice. Paediatr. Respir. Rev. 7(Suppl. 1), S80-S82 (2006). (Pubitemid 43906246)
40. Everard ML. Regimen and device compliance: key factors in determining therapeutic outcomes. J. Aerosol Med. 19(1), 67-73 (2006).
41. van Essen Zandvliet E, Hughes M, Waalkens H, Duiverman E, Pocock S, Kerrebijn K. Effects of 22 months of treatment with inhaled corticosteroids and/or β-2 agonists on lung function, airway responsiveness and symptoms in children with asthma. Am. Rev. Resp. Dis. 146, 547-554 (1992).
42. Haahtela T, Jarvinen M, Kava T et al. Comparison of a β-2 agonist, terbutaline with an inhaled corticosteroid, budesonide, in newly detected asthma. N. Engl. J. Med. 325, 388-392 (1991).
43. van Der Palen J, Klein KC, van Herwaarden CL, Zielhuis G, Seydel E. Multiple inhalers confuse asthma patients. Eur. Respir. J. 14(5), 1034-1037 (1999).
44. Pedersen S. Inhalers and nebulizers: which to choose and why? Eur. Respir. J. 12, 1340-1345 (1996).
45. Geller DE. Clinical side effects during aerosol therapy: cutaneous and ocular effects. J. Aerosol Med. 20(Suppl. 1), S100-S108 (2007). (Pubitemid 46685092)
46. Gulliver T, Morton R, Eid N. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations. Paediatr. Drugs 9(3), 185-194 (2007). (Pubitemid 46849138)
47. Skoner D. Update of growth effects of inhaled and intranasal corticosteroids. Curr. Opin. Allergy Clin. Immunol. 2(1), 7-10 (2002). (Pubitemid 34269864)
48. The childhood asthma management program research group. Long-term effects of budesonide or nedocromil in children with asthma. N. Engl. J. Med. 343(15), 1054-1063 (2000).
49. Newman SP, Weisz AW, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 46(10), 712-716 (1991).
50. Thorsson L, Edsbacker S. Lung deposition of budesonide from a pressurized metereddose inhaler attached to a spacer. Eur. Respir. J. 12, 1340-1345 (1998). (Pubitemid 29011426)
51. Aswania O, Ritson S, Iqbal SM, Bhatt J, Rigby AS, Everard ML. Intra-subject variability in lung dose in healthy volunteers using five conventional portable inhalers. J. Aerosol Med. 17(3), 231-238 (2004). (Pubitemid 39299324)
52. Borgstrom L, Bengtsson T, Derom E, Pauwels R. Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, turbuhaler. Int. J. Pharm. 193(2), 227-230 (2000). (Pubitemid 30001866)
53. Leversha AM, Campanella SG, Aickin RP, Asher MI. Costs and effectiveness of spacer versus nebuliser in young children with moderate and severe acute asthma. J. Pediatr. 497-502 (2000). (Pubitemid 30469591)
54. Dewar AL, Stewart A, Cogswell JJ, Connett GJ. A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital. Arch. Dis. Childhood 421-423 (1999). (Pubitemid 29220175)
55. Gazarian M, Henry R, Wales S et al. Evaluating the effectiveness of evidencebased guidelines for the use of spacer devices in children with acute asthma. Med. J. Aust. 174, 394-397 (2001). (Pubitemid 32385299)
56. Robertson C, Norden M, Fitzgerald J, Connor F, Van Asperen P, Cooper P. Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler. J. Pediatr. Child Health 34(2), 142-146 (1998). (Pubitemid 28201352)
57. Chan PWK, DeBruyne JA. Parental concern towards the use of inhaled therapy in children with chronic asthma. In : Pediatrics International. Blackwell Publishing Limited, Oxford, UK, 547-551 (2000).
58. Apter A, Reisine S, Affleck G, Barrows E, ZuWallack R. Adherence with twice-daily dosing of inhaled steroids. Am. J. Respir. Crit. Care Med. 157(6), 1810-1817 (1998).
59. Rubin BK. What does it mean when a patient says, 'my asthma medication is not working?'. Chest 126(3), 972-981 (2004). (Pubitemid 39258056)
60. Bowton D, Goldsmith W, Haponik E. Substitution of metered-dose inhalers for hand-held nebulizers: success and cost savings in a large, acute-care hospital. Chest 101(2), 305-308 (1992).
61. Tenholder M, Bryson M, Whitlock W. A model for conversion from small volume nebulizer to metered dose inhaler aerosol therapy. Chest 101(2), 305-308 (1992).
62. Summer W, Elston R, Tharpe L, Nelson S, Haponik EF. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. Arch. Intern. Med. 149(3), 618-623 (1989). (Pubitemid 19092860)
63. Restrepo RD, Dickson SK, Rau JL, Gardenhire DS. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir. Care 51(1), 56-61 (2006). (Pubitemid 47471706)
64. Kishida M, Suzuki I, Kabayama H et al. Mouthpiece versus facemask for delivery of nebulized salbutamol in exacerbated childhood asthma. J. Asthma 39, 337 (2002).
65. Lowenthal D, Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr. Pulmonol. 14(3), 192-196 (1992).
66. Mellon M, Leflein J, Walton-Bowen K, Criz-Rivera M, Fitzpatric S, Smith J. Comparable efficacy of administration with facemask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am. J. Respir. Crit. Care Med. 162, 593-598 (2000). (Pubitemid 30647205)
67. Kesser B, Geller D, Amirav I, Fink JB. Baby don't cry: in vitro comparisons of 'baby's breath' aerosol delivery hood versus face mask or blow-by using the saint infant upper airway model and aeroneb go versus t-piece nebulizer. Respir. Care 48(11), 1079 (2003).
68. Rubin BK. Bye-bye, blow-by. Respir. Care 52(8), 981 (2007).
69. Everard ML, Clark AR, Milner AD. Drug delivery from holding chambers with attached facemask. Arch. Dis. Child 67(5), 580-585 (1992).
70. Smaldone GC, Berg E, Nikander K. Variation in pediatric aerosol delivery: importance of facemask. J. Aerosol Med. 18(3), 354-363 (2005). (Pubitemid 41395736)
71. Janssens HM, Tiddens HA. Facemasks and aerosol delivery by metered dose inhalervalved holding chamber in young children: a tight seal makes the difference. J. Aerosol Med. 20(Suppl. 1), S59-S63 (2007). (Pubitemid 46685084)
72. Esposito-Festen JE, Ates B, van Vliet FJ, Verbraak AF, de Jongste JC, Tiddens HA. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J. Aerosol Med. 17(1), 1-6 (2004). (Pubitemid 38520667)
73. Erzinger S, Schueepp KG, Brooks-Wildhaber J, Devadason SG, Wildhaber JH. Facemasks and aerosol delivery in vivo. J. Aerosol Med. 20(Suppl. 1), S78-S83 (2007). (Pubitemid 46685088)
74. Morton RW, Mitchell JP. Design of facemasks for delivery of aerosol-based medication via pressurized metered dose inhaler with valved holding chamber: key issues that affect performance. J. Aerosol Med. 20(Suppl. 1), S29-S42 (2007). (Pubitemid 46685080)
75. Amirav I, Balanov I, Gorenberg M, Groshar D, Luder AS. Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears! Arch. Dis. Child. 88(8), 719-723 (2003). (Pubitemid 36930312)
76. Amirav I, Oron A, Tal G et al. Aerosol delivery in respiratory syncytial virus bronchiolitis: hood or face mask? J. Pediatr. 147(5), 627-631 (2005). (Pubitemid 41598335)
77. Kugelman A, Amirav I, Mor F, Riskin A, Bader D. Hood versus mask nebulization in infants with evolving bronchopulmonary dysplasia in the neonatal intensive care unit. J. Perinatol. 26(1), 31-36 (2006). (Pubitemid 43135252)
78. Wilkes W, Fink J, Dhand R. Selecting an accessory device with a metered-dose inhaler: variable influence of accessory devices on fine particle dose, throat deposition, and drug delivery with asynchronous actuation from a metereddose inhaler. J. Aerosol Med. 14, 351 (2001).
79. Brand PL, van der Baan-Slootweg OH, Heynens JW et al. Comparison of handling and acceptability of two spacer devices in young children with asthma. Acta Paediatr. 90(2), 133-136 (2001). (Pubitemid 32222795)
80. Nagel M, Doyle C, Avvakoumova VI, Mitchell J, Sharpe R. A breath-actuated nebulizer provides greatly reduced fugitive aerosol emissions compared with a continuously operating nebulizer. Presented at: European Respiratory Society Annual Congress. Stockholm, Sweden, 15-19 September 2007.
81. Fink J. Metered-dose inhalers, dry powder inhalers and transitions. Respir. Care 45, 623 (2000).
82. Nikander K, Berg E, Smaldone GC. Jet nebulizers versus pressurized metered dose inhalers with valved holding chambers: effects of the facemask on aerosol delivery. J. Aerosol Med. 20(Suppl. 1), S46-S55 (2007). (Pubitemid 46685082)
83. Tal A, Golan H, Aviram M. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J. Pediatri. 1128(4), 479-484 (1996). (Pubitemid 26114084)
84. Bower L, Barnhart S, Betit P, Czervinske M, Masi-Lynch J, Wilson B. AARC clinical practice guideline: selection of an aerosol delivery device for neonatal and pediatric patients. Respir. Care 40(12), 1325-1335 (1995).
85. Amirav I, Shakked T, Broday DM, Katoshevski D. Numerical investigation of aerosol deposition at the eyes when using a hood inhaler for infants-a 3D simulation. J. Aerosol Med. 21(2), 207-214 (2008).
86. Ari A, Harwood R, Sheard M, Dailey P, Fink JB. In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatr. Pulmonol. 46(8), 795-801 (2011).
87. Bhashyam AR, Wolf MT, Marcinkowski AL et al. Aerosol delivery through nasal cannulas: an in vitro study. J. Aerosol Med. 21(2), 181-188 (2008).
88. Lin HL, Restrepo RD, Gardenhire DS, Rau JL. Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Respir. Care 52(8), 1021-1026 (2007).
89. Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolised drug in infants. Arch. Dis. Child 81(2), 163-165 (1999). (Pubitemid 29349997)
90. Everard ML. Trying to deliver aerosols to upset children is a thankless task. Arch. Dis. Child 82(5), 428 (2000). (Pubitemid 30307778)
91. Murakami G, Igarashi T, Adachi Y et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann. Allergy 64(4), 383-387 (1990). (Pubitemid 20118973)
92. Janssens H, van der Wiel E, Verbraak A, de Jongste J, Merkus P, Tiddens H. Aerosol therapy and the fighting toddler: is administration during sleep an alternative? J. Aerosol Med. 16, 395-400 (2003). (Pubitemid 38120945)
93. Esposito-Festen JE, Ijsselstjin H, Hop W, van Vliet F, de Jongste J, Tiddens H. Aerosol therapy by pMDI-spacer in sleeping young children: to do or not to do? Chest 130, 487-492 (2006). (Pubitemid 44267017)
94. Yilmaz O, Sogut A, Kose U, Sakinci O, Yuksel H. Influence of ambulatory inhaled treatment with different devices on the duration of acute asthma findings in children. J. Asthma 46(2), 191-193 (2009).
95. Wildhaber JH, Dore ND, Wilson JM, Devadason SG, LeSouef PN. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J. Pediatr. 135(1), 28-33 (1999). (Pubitemid 30180558)
96. Mazhar SH, Ismail NE, Newton DA, Chrystyn H. Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation. Br. J. Clin. Pharmacol. 65(3), 334-337 (2008). (Pubitemid 351316916)
97. Verberne AA, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch paediatric asthma study group. Am. J. Respir. Crit. Care Med. 156(3 Pt 1), 688-695 (1997). (Pubitemid 27396402)
98. Gray S, Williams D, Pulliam C, Sirgo M, Bishop A, Donohue J. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch. Intern. Med. 156(9), 984-988 (1996). (Pubitemid 26149124)
99. Allen S, Prior A. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad. Med. J. 78, 37-39 (2002). (Pubitemid 34074914)
100. McFadden ER Jr. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J. Allergy Clin. Immunol. 96(2), 278-283 (1995).
101. Goodman D, Israel E, Rosenberg M, Johnston R, Weiss S, Drazen J. The influence of age, diagnosis and gender on proper use of metered dose inhalers. Am. J. Respir. Crit. Care Med. 150, 1256-1261 (1994). (Pubitemid 24356637)
102. Atkins PJ. Dry powder inhalers: an overview. Respir. Care 50(10), 1304-1312 (2005). (Pubitemid 46173313)
103. Chapman K, Voshaar T, Virchow JC. Inhaler choice in primary practice. Eur. Respir. Rev. 14(96), 117-122 (2005). (Pubitemid 43028769)
104. Voshaar T, App E, Berdel D. Recommendations for the choice of inhalatory systems for drug prescription. Pneumologie 55, 579-586 (2001). (Pubitemid 34043044)
105. Lavorini F, Magnan A, Dubus JC et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir. Med. 102(4), 593-604 (2008).
106. Walia M, Paul L, Satyavani A, Lodha R, Kalaivani M, Kabra SK. Assessment of inhalation technique and determinants of incorrect performance among children with asthma. Pediatr. Pulmonol. 41(11), 1082-1087 (2006). (Pubitemid 44744096)
107. Deerojanawong J, Promsaka na Sakolnakorn V, Prapphal N, Hanrutakorn C, Sritippayawan S. Evaluation of metered-dose inhaler administration technique among asthmatic children and their caregivers in Thailand. Asian Pac. J. Allergy Immunol. 27, 87-93 (2009).